Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:59 am Sale | 2024-02-14 | 13G | PDL BIOPHARMA INC PDLI | DIMENSIONAL FUND ADVISORS LP | 7,392,656 6.500% | -33,847 (-0.46%) | Filing History |
| 2023-02-10 2:42 pm Sale | 2023-02-14 | 13G | PDL BIOPHARMA INC PDLI | DIMENSIONAL FUND ADVISORS LP | 7,426,503 6.500% | -32,390 (-0.43%) | Filing History |
| 2022-02-08 3:52 pm Sale | 2022-02-14 | 13G | PDL BIOPHARMA INC PDLI | DIMENSIONAL FUND ADVISORS LP | 7,458,893 6.500% | -208,704 (-2.72%) | Filing History |
| 2021-02-12 3:20 pm Sale | 2021-02-16 | 13G | PDL BIOPHARMA INC PDLI | DIMENSIONAL FUND ADVISORS LP | 7,667,597 6.700% | -1,863,352 (-19.55%) | Filing History |
| 2021-02-11 4:22 pm Purchase | 2020-12-31 | 13G | PDL BIOPHARMA INC PDLI | BRANDES INVESTMENT PARTNERS LP | 7,046,701 6.170% | 1,235,621 (+21.26%) | Filing History |
| 2021-02-10 7:32 pm Sale | 2020-12-31 | 13G | PDL BIOPHARMA INC PDLI | RENAISSANCE TECHNOLOGIES LLC | 0 0.000% | -8,170,631 (Position Closed) | Filing History |
| 2021-01-11 5:27 pm Purchase | 2020-12-30 | 13D | PDL BIOPHARMA INC PDLI | Silver Point Capital L.P. | 23,783,273 20.800% | 10,269,813 (+76.00%) | Filing History |
| 2021-01-11 4:30 pm Purchase | 2020-12-30 | 13G | PDL BIOPHARMA INC PDLI | Park West Asset Management LLC | 14,397,212 12.600% | 7,679,953 (+114.33%) | Filing History |
| 2020-12-15 6:59 pm Purchase | 2020-12-10 | 13G | PDL BIOPHARMA INC PDLI | Silver Point Capital L.P. | 13,513,460 11.800% | 13,513,460 (New Position) | Filing History |
| 2020-08-28 4:53 pm Purchase | 2020-08-19 | 13G | PDL BIOPHARMA INC PDLI | Park West Asset Management LLC | 6,717,259 5.900% | 923,762 (+15.94%) | Filing History |
| 2020-08-28 4:44 pm Purchase | 2020-08-18 | 13G | PDL BIOPHARMA INC PDLI | Park West Asset Management LLC | 5,793,497 5.100% | 5,793,497 (New Position) | Filing History |
| 2020-05-26 4:34 pm Sale | 2020-05-21 | 13D | Evofem Biosciences, Inc. EVFM | PDL BIOPHARMA INC. PDLI | 1,778 6.300% | -7,111 (-80.00%) | Filing History |
| 2020-03-10 4:42 pm Sale | 2020-03-06 | 13D | PDL BIOPHARMA INC PDLI | ENGINE CAPITAL L.P. | 4,519,994 4.000% | -1,705,849 (-27.40%) | Filing History |
| 2020-02-28 08:33 am Purchase | 2020-02-27 | 13D | PDL BIOPHARMA INC PDLI | ENGINE CAPITAL L.P. | 6,225,843 5.500% | 191,798 (+3.18%) | Filing History |
| 2020-02-13 11:56 am Sale | 2019-12-31 | 13G | PDL BIOPHARMA INC PDLI | RENAISSANCE TECHNOLOGIES LLC | 8,170,631 7.160% | -904,869 (-9.97%) | Filing History |
| 2020-02-12 12:04 pm Sale | 2019-12-31 | 13G | PDL BIOPHARMA INC PDLI | VANGUARD GROUP INC | 5,523,952 4.830% | -4,555,436 (-45.20%) | Filing History |
| 2020-02-12 11:45 am Sale | 2019-12-31 | 13G | PDL BIOPHARMA INC PDLI | DIMENSIONAL FUND ADVISORS LP | 9,530,949 8.350% | -2,922,172 (-23.47%) | Filing History |